T. L'Haridon

502 total citations
2 papers, 3 citations indexed

About

T. L'Haridon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, T. L'Haridon has authored 2 papers receiving a total of 3 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Pulmonary and Respiratory Medicine, 1 paper in Oncology and 1 paper in Radiology, Nuclear Medicine and Imaging. Recurrent topics in T. L'Haridon's work include Cancer Treatment and Pharmacology (1 paper), Breast Cancer Treatment Studies (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). T. L'Haridon is often cited by papers focused on Cancer Treatment and Pharmacology (1 paper), Breast Cancer Treatment Studies (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). T. L'Haridon collaborates with scholars based in France. T. L'Haridon's co-authors include Philippe Barthélémy, Karim Fizazi, Géraldine Martineau, Christine Théodore, P Soulié, B. Lucas, Alain Zannetti, Isabelle Borget, Philippe Beuzeboc and Aude Fléchon and has published in prestigious journals such as Cancer Research and Annals of Oncology.

In The Last Decade

T. L'Haridon

2 papers receiving 3 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. L'Haridon France 2 2 2 1 1 1 2 3
Carolyn M Butcher Australia 2 2 1.0× 2 1.0× 1 1.0× 4 8
Andy Beck United States 3 2 1.0× 2 1.0× 5 9
N. Schultz United States 2 2 1.0× 2 1.0× 1 1.0× 2 3
T. Duckett Jones United States 2 3 1.5× 2 1.0× 3 4
Yu-Qi Ping China 2 2 1.0× 2 1.0× 3 3
Hannah Fry United Kingdom 2 2 1.0× 2 1.0× 3 5
Y. T. Gu China 1 2 1.0× 2 1.0× 2 2
J Jelenkovic Serbia 2 3 1.5× 2 1.0× 2 4
Agnes Reschke United States 3 3 1.5× 2 1.0× 4 8
Kiara Siex United States 2 2 1.0× 2 1.0× 3 4

Countries citing papers authored by T. L'Haridon

Since Specialization
Citations

This map shows the geographic impact of T. L'Haridon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. L'Haridon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. L'Haridon more than expected).

Fields of papers citing papers by T. L'Haridon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. L'Haridon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. L'Haridon. The network helps show where T. L'Haridon may publish in the future.

Co-authorship network of co-authors of T. L'Haridon

This figure shows the co-authorship network connecting the top 25 collaborators of T. L'Haridon. A scholar is included among the top collaborators of T. L'Haridon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. L'Haridon. T. L'Haridon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Fizazi, Karim, R. Delva, Gwénaëlle Gravis, et al.. (2017). Patient preference between Cabazitaxel and Docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC): Results from the CABADOC randomized trial. Annals of Oncology. 28. v276–v277. 1 indexed citations
2.
Bourgeois, Hugues, P Soulié, B. Lucas, et al.. (2012). Abstract OT3-3-04: ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients.. Cancer Research. 72(24_Supplement). OT3–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026